首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2077581

IPV疫苗市場：按疫苗品牌、分銷管道、地區、規模、佔有率、前景和機會進行分析（2025-2032年）

IPV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年IPV疫苗市值為2.177億美元，預計2033年將達到3.954億美元。預計從2026年到2033年，其複合年成長率將達到8.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.177億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	8.90%	2033年市場規模預測：	3.954億美元

去活化脊髓灰質炎疫苗（IPV）也稱為索爾克疫苗。脊髓灰質炎疫苗有兩種：去活化脊髓灰質炎疫苗和口服脊髓灰質炎疫苗。 IPV疫苗主要透過手臂或腿部注射接種。

對雞蛋或鏈黴素等藥物過敏的人不應接種注射型去活化小兒麻痺疫苗（IPV）。 IPV 僅適用於長期接受類固醇治療、患有癌症、正在接受化療或與未接種疫苗的成年人共同居住的患者。

2026 年全球 IPV 疫苗市場價值為 2.177 億美元，預計到 2033 年將成長至 3.954 億美元，預測期內複合年成長率預計為 8.9%。

市場動態

世界各國政府正採取措施提高民眾對脊髓灰質炎疫苗意識提升，以防止疫情在其人群中爆發。各國政府正在實施有益的免疫接種計劃，為低收入者提供疫苗接種，預計這將為近期全球去活化脊髓灰質炎疫苗（IPV）市場的成長創造非常有利的環境。例如，2020年9月，加納衛生局（GHS）啟動了一系列脊髓灰質炎接種和免疫宣傳活動，以防止脊髓灰質炎在高風險地區傳播。這些宣傳活動將使用去活化脊髓灰質炎疫苗（IPV），並為加納所有地區2016年1月至2018年6月期間出生的所有嬰兒接種疫苗。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球IPV疫苗市場的主要參與者進行了分析：公司概況、財務績效、產品系列、市場佔有率、分銷策略、主要發展、策略和未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份IPV疫苗市場報告針對產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球IPV疫苗市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

市場相關人員的聲音
競爭對手儀錶板
按公司分類的市佔率分析（2026 年，全球）

第10章公司概況：全球IPV疫苗市場

Sanofi
- 公司簡介
- 產品和服務組合
- 近期趨勢和最新信息
- 戰略概覽
Serum Institute of India Pvt. Ltd.
Bharat BIoTech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea BIoTec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac BIoTech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited
興衰
分析師觀點
一致的機會地圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4965

Ipv Vaccines Market is estimated to be valued at USD 217.7 Mn in 2026 and is expected to reach USD 395.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 217.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.90%	2033 Value Projection:	USD 395.4 Mn

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 217.7 Mn in 2026 and is expected to increase to US$ 395.4 Mn by 2033, registering a CAGR of 8.9% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

Global IPV Vaccines Market, by Vaccine Brand (Revenue, USD Mn, 2021 - 2033)
Poliovac (Pfs/Sd)
Shanipv
Poliorix
Ipol/Imovax
Polymilex
Global IPV Vaccines Market, by Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Private
Public
Global IPV Vaccines Market, by Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles:
GlaxoSmithKline Plc*
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
Sanofi S.A.
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Brand
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Vial Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Company Market Share Analysis
Import-Export Analysis
Regulatory Scenario
Pricing Analysis
Epidemiology
Healthcare Spending, by Country
Vaccination Rate, by Country
Manufacturing Capacities
Distributors Landscape
Investments & Funding
Competitive Snapshot
Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2033 (US$ Million)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033
- Market Y-o-Y Growth Comparison (%), 2021 - 2033
- Segment Trends
POLIOVAC (PFS/SD), 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
SHANIPV, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
POLIORIX, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
IPOL/IMOVAX, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
POLYMILEX, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2021 - 2033 (US$ Million)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033
- Market Y-o-Y Growth Comparison (%), 2021 - 2033
- Segment Trends
Combination Vaccine, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
Single Vaccine, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2021 - 2033 (US$ Million)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033
- Market Y-o-Y Growth Comparison (%), 2021 - 2033
- Segment Trends
1 Dose Vial, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
5 Dose Vial, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
10 Dose Vial, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2033 (US$ Million)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033
- Market Y-o-Y Growth Comparison (%), 2021 - 2033
- Segment Trends
Public, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)
Private, 2021 - 2033(US$ Million)
- Introduction
- Market Size and Forecast, 2021 - 2033, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2021 - 2033 (US$ Million)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, (US$ Million)
- Market Y-o-Y Growth Comparison (%), 2021 - 2033, (US$ Million)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - Asean
  - Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (US$ Million)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2026 - Global

10. Company Profiles - Global IPV Vaccines Market

Sanofi*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea Biotec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac Biotech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited.
Section 10: Wheel of Fortune
Wheel of Fortune
Analyst View
Coherent Opportunity Map